| 000 | 01839 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514214004.0 | ||
| 264 | 0 | _c20050726 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a1019-6439 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBérubé, Mélanie | |
| 245 | 0 | 0 |
_aRole of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cFeb 2005 |
||
| 300 |
_a405-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCell Adhesion |
| 650 | 0 | 4 | _aCell Cycle |
| 650 | 0 | 4 | _aCell Death |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 |
_aCollagen Type IV _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
| 650 | 0 | 4 |
_aFibronectins _xmetabolism |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrins _xmetabolism |
| 650 | 0 | 4 |
_aLaminin _xmetabolism |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUveal Neoplasms _xdrug therapy |
| 700 | 1 | _aTalbot, Mariève | |
| 700 | 1 | _aCollin, Charles | |
| 700 | 1 | _aPaquet-Bouchard, Carine | |
| 700 | 1 | _aGermain, Lucie | |
| 700 | 1 | _aGuérin, Sylvain L | |
| 700 | 1 | _aPetitclerc, Eric | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 26 _gno. 2 _gp. 405-13 |
|
| 999 |
_c15324622 _d15324622 |
||